Globeflex Capital L P Immuno Gen, Inc. Transaction History

Globeflex Capital L P

  • $1.03 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
SELL
$14.09 - $19.87 $9,792 - $13,809
-695 Reduced 5.95%
10,978 $174,000
Q2 2023

Aug 14, 2023
BUY
$3.75 - $20.05 $43,773 - $234,043
11,673 New
11,673 $220,000
Q3 2022

Nov 14, 2022
BUY
$4.48 - $6.47 $212,786 - $307,305
47,497 New
47,497 $227,000

Others Institutions Holding IMGN

# of Institutions
8
Shares Held
1.41M
Call Options Held
0
Put Options Held
0
View Full List

About ImmunoGen, Inc.

IMGN Quotes by TradingView
  • Ticker IMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 220,712,992
  • Description
  • ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...
More about IMGN
Track This Portfolio

Track Globeflex Capital L P Portfolio

Follow Globeflex Capital L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Globeflex Capital L P, based on Form 13F filings with the SEC.

News

Stay updated on Globeflex Capital L P with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email